Csete J., Elliott R., Fischer В. «Viral Time Bomb»: Health and Human Rights Challenges in Addressing Hepatitis С in Canada. Toronto: Canadian HIV/AIDS Legal Network, Centre for Addictions Research of ВС and Centre for Applied Research in Mental Health and Addiction. Canada, 2008. 22 p. URL: http://www.aidslaw.ca/site/wp-content/uploads/2013/ll/ViralTime Bomb-ENG.pdf (November 22, 2015).http://www.aidslaw.ca/site/wp-content/uploads/2013/ll/ViralTime

Guidelines on diagnostics and treatment of hepatitis С in adults. Moscow: Russian Federation viral hepatites expert group, 2013.

Онищенко Г.Г., Шахгильдян И.В., Михайлов М.И. Вирусные гепатиты в России // Мир вирусных гепатитов. 2003. Т. 7, № 8. С. 9–11. [Onishchenko G.G., Shakhgildyan I.V., Mikhailov M.I. Viral hepatitis in Russia. World of Viral Hepatitis. 2003. Vol. 7, No. 8. pp. 9–11 (In Russ.)].

Platt L., Easterbrook P., Gower E., McDonald B., Sabin K., McGowan C., Yanny I., Razavi H., Vickerman P. Prevalence and burden of HCV co-infection in people living with HIV: a global systematic review and meta-analysis. Lancet Infect. Dis, 2016, Vol. 16, No. 7, pp. 797–808.

Кравченко А.В., Канестри В.Г., Куимова У.А., Ладная H.H. Терапия хронического гепатита С у больных ВИЧ-инфекцией в Российской Федерации: достижения и перспективы // V конференция по ВИЧ/СПИДу в Восточной Европе и Центральной Азии: тезисы докладов, 23– 25 марта 2016. Москва, 2016. С. 70–71. [Kravchenko A.V., Kanestri V.G., Kuimova U.A., Ladnaya N.N. Therapy of chronic hepatitis C in HIV infected patients in the Russian Federation: achievements and prospects. V Conference on HIV/AIDS in Eastern Europe and Central Asia, Abstracts of Papers, March 23–25, Moscow, 2016, pp. 70–71 (In Russ.)].

Benhamou Y., Bochet M., Martino D. Liver fibrosis progression in human immunodeficiency virus and hepatitis С virus coinfected patients. The Multivirc Group. J. Hepatology, 1999, Vol. 30, No. 4, pp. 1054–1058.

Kramer J.R., Kowalkowski M.A., Duan Z., Chiao E.Y. The effect of HIV viral control on the incidence of hepatocellular carcinoma in veterans with hepatitis С and HIV coinfection. J. Acquir. Immune Defic. Syndr., 2015, Vol. 68, No. 4, pp. 456–462.

Alter M.J. Epidemiology of viral hepatitis and HIV co-infection. J. Hepatology, 2006, Vol. 44, pp. s6–s9. 9. Casado J.L., Quereda С., Moreno A., Pérez-Elías M.J., Martí-Belda P., Moreno S. Regression of liver fibrosis is progressive after sustained virological response to HCV therapy in patients with hepatitis С and HIV coinfection. J. Viral Hepat., 2013, Vol. 20, No. 12, pp. 829–837.

Simmons В., Saleem J., Heath K., Cooke G.S., Hill A. Long-term treatment outcomes of patients infected with hepatitis С virus: a systematic review and meta-analysis of the survival benefit of achieving a sustained virological response. Clin. Infect. Dis., 2015, Vol. 61, No. 5, pp. 730–740.

Hatzakis A., Chulanov V., Gadano A.C. The present and future disease burden of hepatitis С virus (HCV) infection with today’s treatment paradigm. J. Viral Hepat., 2015, Vol. 22, Suppl. 1, pp. 26–45.

Wedemeyer H., Dore G.J., Ward J.W. Estimates on HCV disease burden worldwide — filling the gaps. J. Viral Hepat., 2015, Vol. 22, Suppl. 1, pp. 1–5.

Чуланов В.П. Эпидемиология хронического гепатита С. Современные возможности молекулярной диагностики и мониторинга заболевания // Хронический гепатит С — новые возможности прямой противовирусной терапии: обучающий семинар BMS, 24 июня. Москва, 2016 (устное сообщение). [Chulanov V.P. Epidemiology of chronic hepatitis C. Modern capabilities of molecular diagnosis and monitoring of disease. Chronic hepatitis C — new opportunities for direct antiviral therapy: Seminar BMS, 24 June, Moscow, 2016 (Oral presentation) (In Russ.)].

EASL Clinical Practice Guidelines: Management of hepatitis С virus infection. J. Hepatol., 2011, No. 55, pp. 245–264.

The European Association for the Study of the Liver (EASL). Recommendations on treatment of hepatitis C, 2015.

Seef L.B., Hoofnagle J.H. The National Institute of Health Consensus Development Conference Management of Hepatitis C 2002. Clin. Liver Dis., 2003, No. 7, pp. 261–285.

Сюткин В.Е. Новые возможности увеличения эффективности противовирусной терапии больных ХГC // Инфекционные болезни. 2009. Т. 7, № 2. С. 55–59. [Syutkin V.E. New opportunities to increase the effectiveness of antiviral therapy for CHC patients. Infectious Diseases, 2009, Vol. 7, No. 2, pp. 55–59 (In Russ.)].

Покровский В.В., Юрин О.Г., Кравченко А.В., Беляева В.В., Ермак Т.Н., Канестри В.Г., Шахгильдян И.В., Козырина Н.В., Буравцова В.В., Нарсия Р.С., Хохлова О.Н., Покровская А.В., Ефремова О.С., Коннов В.В., Куимова У.А., Попова А.А., Воронин Е.Е., Афонина Л.Ю., Васильева И.А., Зимина В.Н. Протоколы диспансерного наблюдения и лечения больных ВИЧ-инфекцией 2015 // Эпидемиология и инфекционные болезни. Актуальные вопросы. 2015. № 6, Приложение. 120 с. [Pokrovsky V.V., Yurin O.G., Kravchenko A.V., Belyaeva V.V., Ermak T.N., Kanestri V.G., Shakhgildyan I.V., N. Kozyrina N.V., Buravtsova V.V., Nursiya R.S., Khokhlova O.N., Pokrovskaya A.V., Efremova O.S., Konnov V.V., Kuimova U.A., Popova A.A., Voronin E.E., Afonina L.Yu., Vasil’eva I.A., Zimina V.N. Protocols dispensary observation and treatment of patients with HIV-infection 2015. Epidemiology and Infectious Diseases. The Actual Issues, 2015, No. 6, Suppl., 120 p. (In Russ.)].

Guidelines for the Use of Antiretroviral Agents in HIV-l-Infected Adults and Adolescents. Developed by the Panel on Clinical Practices for Treatment of HIV Infection convened by the Department of Health and Human Services (DHHS) January 28, 2016 [Электронный ресурс]. URL: http://AIDSinfo.nih.gov.http://AIDSinfo.nih.gov

Yu M.L., Lin S.M., Chuang W.L. A sustained virological response to interferon/ribavirin reduces hepatocellular carcinoma and improves survival in chronic hepatitis С a nationwide, multicenter study in Taiwan. Antivir. Ther., 2006, No. 11, pp. 985–994.

Азовцева О.В., Архипова Е.И., Архипов Г.С. Клинико-генотипическая характеристика коинфекции вирусного гепатита С и ВИЧ // ВИЧ-инфекция и иммуносупрессии. Т. 2, № 2. 2010. С. 42–47. [Azovtzeva O.V., Arkhipova E.I., Arkhipov G.S. Clinical and genotypic characteristics of coinfection of hepatitis C virus and HIV. HIV Infection and Immunosuppressive Disorders, Vol. 2, No. 2, 2010, pp. 42–47 (In Russ.)].